Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Neural cell adhesion molecule 2 as a target molecule for prostate and breast cancer gene therapy.

Takahashi S, Kato K, Nakamura K, Nakano R, Kubota K, Hamada H.

Cancer Sci. 2011 Apr;102(4):808-14. doi: 10.1111/j.1349-7006.2011.01855.x. Epub 2011 Feb 25.

2.

Carcinoembryonic antigen-targeted selective gene therapy for gastric cancer through FZ33 fiber-modified adenovirus vectors.

Tanaka T, Huang J, Hirai S, Kuroki M, Kuroki M, Watanabe N, Tomihara K, Kato K, Hamada H.

Clin Cancer Res. 2006 Jun 15;12(12):3803-13.

3.

Exploration of target molecules for prostate cancer gene therapy.

Suzuki K, Nakamura K, Kato K, Hamada H, Tsukamoto T.

Prostate. 2007 Aug 1;67(11):1163-73.

PMID:
17516570
4.

Gene therapy for prostate cancer using the cytosine deaminase/uracil phosphoribosyltransferase suicide system.

Miyagi T, Koshida K, Hori O, Konaka H, Katoh H, Kitagawa Y, Mizokami A, Egawa M, Ogawa S, Hamada H, Namiki M.

J Gene Med. 2003 Jan;5(1):30-7.

PMID:
12516049
5.

EpCAM- and EGFR-targeted selective gene therapy for biliary cancers using Z33-fiber-modified adenovirus.

Kawashima R, Abei M, Fukuda K, Nakamura K, Murata T, Wakayama M, Seo E, Hasegawa N, Mizuguchi H, Obata Y, Hyodo I, Hamada H, Yokoyama KK.

Int J Cancer. 2011 Sep 1;129(5):1244-53. doi: 10.1002/ijc.25758. Epub 2011 Jan 6.

6.

Selective gene transfer into neurons via Na,K-ATPase beta1. Targeting gene transfer with monoclonal antibody and adenovirus vector.

Ishii K, Nakamura K, Kawaguchi S, Li R, Hirai S, Sakuragi N, Wada T, Kato K, Yamashita T, Hamada H.

J Gene Med. 2008 Jun;10(6):597-609. doi: 10.1002/jgm.1164.

PMID:
18383483
7.
8.

[Bystander effect of target-regulated uracil phosphoribosyltransferase/5-fluorouracil suicide gene system on prostate cancer cell].

Zhao FJ, Li H, Zeng H, Wei Q, Li X.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2008 May;39(3):394-7. Chinese.

PMID:
18575323
10.

Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells.

Lowe SL, Rubinchik S, Honda T, McDonnell TJ, Dong JY, Norris JS.

Gene Ther. 2001 Sep;8(18):1363-71.

11.

Adenovirus-mediated tissue-targeted expression of a caspase-9-based artificial death switch for the treatment of prostate cancer.

Xie X, Zhao X, Liu Y, Zhang J, Matusik RJ, Slawin KM, Spencer DM.

Cancer Res. 2001 Sep 15;61(18):6795-804.

12.

Prostate specific membrane antigen (PSMA) is a tissue-specific target for adenoviral transduction of prostate cancer in vitro.

Kraaij R, van Rijswijk AL, Oomen MH, Haisma HJ, Bangma CH.

Prostate. 2005 Feb 15;62(3):253-9.

PMID:
15389777
13.

Transcriptional targeting modalities in breast cancer gene therapy using adenovirus vectors controlled by alpha-lactalbumin promoter.

Li X, Zhang J, Gao H, Vieth E, Bae KH, Zhang YP, Lee SJ, Raikwar S, Gardner TA, Hutchins GD, VanderPutten D, Kao C, Jeng MH.

Mol Cancer Ther. 2005 Dec;4(12):1850-9.

14.

Adenovirus-mediated transduction of Escherichia coli uracil phosphoribosyltransferase gene sensitizes cancer cells to low concentrations of 5-fluorouracil.

Kanai F, Kawakami T, Hamada H, Sadata A, Yoshida Y, Tanaka T, Ohashi M, Tateishi K, Shiratori Y, Omata M.

Cancer Res. 1998 May 1;58(9):1946-51.

15.
17.

Effective gene therapy of biliary tract cancers by a conditionally replicative adenovirus expressing uracil phosphoribosyltransferase: significance of timing of 5-fluorouracil administration.

Seo E, Abei M, Wakayama M, Fukuda K, Ugai H, Murata T, Todoroki T, Matsuzaki Y, Tanaka N, Hamada H, Yokoyama KK.

Cancer Res. 2005 Jan 15;65(2):546-52.

18.

In vivo cancer gene therapy by adenovirus-mediated transfer of a bifunctional yeast cytosine deaminase/uracil phosphoribosyltransferase fusion gene.

Erbs P, Regulier E, Kintz J, Leroy P, Poitevin Y, Exinger F, Jund R, Mehtali M.

Cancer Res. 2000 Jul 15;60(14):3813-22.

19.

Chemo-radio-gene therapy for colorectal cancer cells using Escherichia coli uracil phosphoribosyltransferase gene.

Koyama F, Fujii H, Mukogawa T, Ueno M, Hamada H, Ishikawa H, Doi S, Nakao T, Matsumoto H, Shimatani H, Takeuchi T, Nakajima Y.

Anticancer Res. 2003 Mar-Apr;23(2B):1343-8.

PMID:
12820392
20.

Virus specific immune responses after human neoadjuvant adenovirus-mediated suicide gene therapy for prostate cancer.

van der Linden RR, Haagmans BL, Mongiat-Artus P, van Doornum GJ, Kraaij R, Kadmon D, Aguilar-Cordova E, Osterhaus AD, van der Kwast TH, Bangma CH.

Eur Urol. 2005 Jul;48(1):153-61. Epub 2005 Mar 9.

PMID:
15967266

Supplemental Content

Support Center